TrialThe Journal of infectious diseases2025

Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season.

Hannah Bahakel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.